Home › Cancro pancreatico › Michigan › Ann Arbor
Studi clinici su Cancro pancreatico a Ann Arbor, MI
14 studi su Cancro pancreatico cercano partecipanti presso sedi a Ann Arbor e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
In reclutamentoFase 3
- Investigative Site US006, Ann Arbor
- Investigative Site US012, Ypsilanti · a 7 mi di distanza
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
In reclutamentoFase 3
- University of Michigan Health - University of Michigan Medical Center, Ann Arbor
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
In reclutamentoFase 1/2
- University of Michigan Medical School Rogel Cancer Center, Ann Arbor
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
In reclutamentoFase 2
- Local Institution - 0119, Ann Arbor
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
In reclutamentoStudio osservazionale
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · a 7 mi di distanza
- e altri 5
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
In reclutamentoFase 2
- University of Michigan, Ann Arbor
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
In reclutamentoFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · a 7 mi di distanza
- e altri 5
Pancreatic Cancer Early Detection Consortium
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- University of Michigan, Ann Arbor
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer
In reclutamentoFase 1
- University of Michigan Health, Ann Arbor
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
In reclutamentoFase 1/2
- University of Michigan, Ann Arbor
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
In reclutamentoFase 2
- Ohio State University-Telemedicine, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Ann Arbor
The Cancer of the Pancreas Screening-5 CAPS5)Study
In reclutamentoFase 3
- University of Michigan, Ann Arbor
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
In reclutamentoFase 1/2
- University of Michigan, Ann Arbor
Studi su Cancro pancreatico in altre città
- Houston, TX61 studi
- New York City, NY60 studi
- Boston, MA43 studi
- Nashville, TN39 studi
- Los Angeles, CA35 studi
- St. Louis, MO33 studi
- Arlington, VA33 studi
- Baltimore, MD31 studi
- San Antonio, TX31 studi
- Philadelphia, PA26 studi
- Tampa, FL26 studi
- Durham, NC24 studi
Altri studi a Ann Arbor
- Cancro al seno27 studi
- Cancro alla prostata27 studi
- Cancro del polmone non a piccole cellule26 studi
- Cancro (tutti i tipi)25 studi
- Cancro ai polmoni23 studi
- Cancro colorettale23 studi
- Insufficienza cardiaca22 studi
- Leucemia mieloide acuta17 studi
- Malattie cardiovascolari16 studi
- Melanoma12 studi
- Ictus12 studi
- Carcinoma a cellule squamose della testa e del collo12 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.